ALX 40-4C
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


ALX 40-4C
Description :
ALX 40-4C is a small peptide inhibitor of the chemokine receptor CXCR4, inhibits SDF-1 from binding CXCR4 with a Ki of 1 μM, and suppresses the replication of X4 strains of HIV-1; ALX 40-4C Trifluoroacetate also acts as an antagonist of the APJ receptor, with an IC50 of 2.9 μM.UNSPSC :
12352202Target :
Apelin Receptor (APJ) ; CXCRType :
PeptidesRelated Pathways :
GPCR/G Protein; Immunology/InflammationApplications :
Metabolism-protein/nucleotide metabolismField of Research :
Infection; EndocrinologyAssay Protocol :
https://www.medchemexpress.com/ALX_40-4C.htmlSolubility :
10 mM in H2OSmiles :
N=C(N)NCCC[C@H](C(N)=O)NC([C@@H](CCCNC(N)=N)NC([C@@H](CCCNC(N)=N)NC([C@@H](CCCNC(N)=N)NC([C@@H](CCCNC(N)=N)NC([C@@H](CCCNC(N)=N)NC([C@@H](CCCNC(N)=N)NC([C@@H](CCCNC(N)=N)NC([C@H](NC(C)=O)CCCNC(N)=N)=O)=O)=O)=O)=O)=O)=O)=OMolecular Formula :
C56H113N37O10Molecular Weight :
1464.74References & Citations :
[1]Doranz BJ, et al. Safe use of the CXCR4 inhibitor ALX40-4C in humans. AIDS Res Hum Retroviruses. 2001 Apr 10;17 (6) :475-86.|[2]Armand-Ugón M, et al. HIV-1 resistance to the gp41-dependent fusion inhibitor C-34. Antiviral Res. 2003 Jul;59 (2) :137-42.|[3]Zhou N, et al. Binding of ALX40-4C to APJ, a CNS-based receptor, inhibits its utilization as a co-receptor by HIV-1. Virology. 2003 Jul 20;312 (1) :196-203.Shipping Conditions :
Room temperatureScientific Category :
PeptidesClinical Information :
No Development ReportedIsoform :
CXCR4CAS Number :
[143413-49-4]

